Pomerantz Appointed Lead Counsel in Fortress Biotech Securities Litigation

On April 19, 2021, U.S. District Judge Kiyo A. Matsumoto of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiffs Yasser Abed and Evay Avbenake in Cushman v. Fortress Biotech, Inc., 20-cv-5767 (E.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Fortress Biotech, Inc. failed to disclose that IV Tramadol…